Advertisement
U.S. markets close in 6 hours 30 minutes

Structure Therapeutics Inc. (GPCR)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
34.65+0.64 (+1.88%)
As of 09:30AM EST. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.95B
Enterprise Value 1.04B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.17
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -13.46

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-37.12%
S&P500 52-Week Change 331.45%
52 Week High 366.38
52 Week Low 326.61
50-Day Moving Average 338.67
200-Day Moving Average 339.65

Share Statistics

Avg Vol (3 month) 3735.81k
Avg Vol (10 day) 3996.42k
Shares Outstanding 557.26M
Implied Shares Outstanding 646.39M
Float 8153.52M
% Held by Insiders 14.84%
% Held by Institutions 1107.26%
Shares Short (Oct 31, 2024) 410.44M
Short Ratio (Oct 31, 2024) 415.69
Short % of Float (Oct 31, 2024) 421.67%
Short % of Shares Outstanding (Oct 31, 2024) 418.26%
Shares Short (prior month Sep 30, 2024) 410.55M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-13.01%
Return on Equity (ttm)-17.69%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -121.84M
Net Income Avi to Common (ttm)-100.44M
Diluted EPS (ttm)-2.16
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)927.12M
Total Cash Per Share (mrq)5.4
Total Debt (mrq)4.67M
Total Debt/Equity (mrq)0.51%
Current Ratio (mrq)41.38
Book Value Per Share (mrq)9.76

Cash Flow Statement

Operating Cash Flow (ttm)-102.76M
Levered Free Cash Flow (ttm)-68.36M